{'fraction_non_alphanumeric': 0.04006677796327212, 'fraction_numerical': 0.01669449081803005, 'mean_word_length': 5.521739130434782, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
P42: CLINICAL FEATURES OF PAEDIATRIC PATIENTS WITH FOOD PROTEIN‐INDUCED ENTEROCOLITIS SYNDROME FROM A LARGE TERTIARY CENTRE COHORT

in the Probiotic and Peanut Oral Immunotherapy (PPOIT) randomised placebo-controlled trial at baseline, immediately after completing 18 months of treatment, 3 months post-treatment and 4 years post-treatment. Peanut component (Arah 1, 2, 3) sIgE and sIgG4 were measured by ImmunoCAP. Two-tailed t-tests on log-transformed values were used for point-in-time between-group comparisons and generalised estimating equations (GEE) were used to compare longitudinal trends.